Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

TSX:GUD - Post Discussion

Knight Therapeutics Inc > Observation - Complaining about how cheap a stock
View:
Post by schocor on Dec 17, 2020 5:40pm

Observation - Complaining about how cheap a stock

This is a weird little board. Most come on here to complain about how cheap the stock is. "It is about the same price as it was in March - airlines are doing better" - clearly not written by a CFA. "All the stock does is go down" - what about the fundamentals of the company there Einstein? It is pretty clear to me that a lot of people that SHOULD have known better bought this stock with instant $$$ signs in their eyes. Scazenfreud is - I believe - the emotion elicited when I read their responses on here.
Comment by MrMugsy on Dec 17, 2020 9:43pm
Well said Schocor. I like the way you think.
Comment by MrMugsy on Dec 17, 2020 11:09pm
And the fundamentals is why we're here ... and ... why Knight has ventured into Latin America.  Patience is required as they build it. "Latin America Pharmaceutical Products CMO Market was valued at US$ 13,266.5 Mn in 2019 and is forecast to reach a value of US$ 40,070.3 Mn by 2027 at a CAGR of 14.8% between 2020 and 2027."
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities